|
|
Volumn 27, Issue 11, 2009, Pages 968-969
|
|
Genentech obtains proof of concept for hedgehog inhibition
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BMS 833923;
GDC 0449;
IPI 926;
PF 04449913;
SONIC HEDGEHOG PROTEIN;
UNCLASSIFIED DRUG;
BASAL CELL CARCINOMA;
CELL DIFFERENTIATION;
CHRONIC MYELOID LEUKEMIA;
CLINICAL TRIAL;
COLORECTAL CANCER;
ESOPHAGUS CANCER;
HEMATOLOGIC MALIGNANCY;
HUMAN;
LUNG SMALL CELL CANCER;
MEDULLOBLASTOMA;
METASTASIS;
MYELOMA;
NONHUMAN;
NOTE;
OVARY CANCER;
PRIORITY JOURNAL;
SOLID TUMOR;
ANILIDES;
ANIMALS;
ANTINEOPLASTIC AGENTS;
CLINICAL TRIALS AS TOPIC;
DROSOPHILA MELANOGASTER;
DRUG INDUSTRY;
HEDGEHOG PROTEINS;
HUMANS;
LIGANDS;
NEOPLASMS;
NEOPLASTIC STEM CELLS;
PYRIDINES;
SIGNAL TRANSDUCTION;
ERINACEIDAE;
|
|
EID: 70449371472
PISSN: 10870156
EISSN: 15461696
Source Type: Journal
DOI: 10.1038/nbt1109-968 Document Type: Note |
|
Times cited : (8)
|
|
References (0)
|
